Pinnacle Wealth Management Advisory Group’s AstraZeneca AZN Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$513K	Hold	2,707	–	–	0.03%	280
2026 Q1	$534K	Buy	+2,707	New	+$522K	0.04%	263

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's AZN Position: Q2 2026 in Review

Pinnacle Wealth Management Advisory Group held its AstraZeneca (AZN) position steady in Q2 2026 at 2,707 shares worth $513K. The position accounts for 0.03% of the portfolio, ranked #280.

Pinnacle Wealth Management Advisory Group first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $534K in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Pinnacle Wealth Management Advisory Group held 2,707 shares of AstraZeneca worth $513K as of Q2 2026.
Pinnacle Wealth Management Advisory Group left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.03% of Pinnacle Wealth Management Advisory Group's portfolio in Q2 2026, its #280 holding.
Pinnacle Wealth Management Advisory Group first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
Pinnacle Wealth Management Advisory Group's AstraZeneca position peaked at $534K in Q1 2026.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2026, filed 5 Aug 2026.